Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil and Abraxane in Metastatic Breast Cancer
NCT00442260Phase 2Completed
- Sponsor
- West Virginia University
- Start
- Feb 2007
- Primary completion
- Oct 2008
- Modality
- Polymer-based Nanoparticles, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin, nab-paclitaxel in breast cancer, sponsored by West Virginia University. Started Feb 2007; status: completed.
02
Drugs
pegylated liposomal doxorubicinnab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00442260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442260.